Health AI Central
Share:
Peer-Reviewed Publication
Am J Manag Care2025;31(10):e302-e307.October 1, 2025Comparative Study

Value-based care interventions and management of CKD progression.

Melissa Feeney, Joseph Mehltretter, Tammy Cheung, Emily Simon1, Farhad Modarai
1Strive Health, 1125 17th St #1000, Denver, CO 80202. Email: esimon@strivehealth.com.
PubMed DOI

Abstract

OBJECTIVES: This study aimed to evaluate the effectiveness of value-based care (VBC) interventions in slowing the progression of chronic kidney disease (CKD), as measured by changes in estimated glomerular filtration rate (eGFR) over time. STUDY DESIGN: This retrospective cohort study used eGFR values from 2017 to 2023 to evaluate 623 patients with stage 3b or 4 CKD with routine eGFR testing who…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.